FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Elizabeth Mallon

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Genes & Molecular Sequences

Genes, erbB-2

Physiology

Gene Amplification

Co-author Network

Publications

TOP 3
Zahra M A Mohammed; Clare Orange; Julie C Doughty; Joanne Edwards; Elizabeth Mallon; Donald C McMillan; James J Going
Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis.
Z M A Mohammed; C Orange; JC Doughty; B Elsberger; J J Going; Elizabeth Mallon; Donald C McMillan; Joanne Edwards
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.
Jack Cuzick; Mitch Dowsett; Ian O Ellis; Aman U Buzdar; Andrew R Green; Anthony Howell; Elizabeth Mallon; Silvia Pineda; Emma Quinn; Janine Salter; Christopher Wale; Lila Zabaglo; John F Forbes
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Elizabeth Mallon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Zahra M A Mohammed; Clare Orange; Julie C Doughty; Joanne Edwards; Elizabeth Mallon; Donald C McMillan; James J Going
Breast cancer outcomes by steroid hormone receptor status assessed visually and by computer image analysis.
Histopathology 2012;61(2):283-92.
2012: Z M A Mohammed; C Orange; JC Doughty; B Elsberger; J J Going; Elizabeth Mallon; Donald C McMillan; Joanne Edwards
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer.
British journal of cancer 2012;106(2):383-8.
2011: Jack Cuzick; Mitch Dowsett; Ian O Ellis; Aman U Buzdar; Andrew R Green; Anthony Howell; Elizabeth Mallon; Silvia Pineda; Emma Quinn; Janine Salter; Christopher Wale; Lila Zabaglo; John F Forbes
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011;29(32):4273-8.
2011: Mitch Dowsett; John Forbes; Antony Howell; Elizabeth Mallon; S Pineda; Janine Salter; Lila Zabaglo; Aman U Buzdar; Jack Cuzick
Predictive algorithms for adjuvant therapy: TransATAC.
Steroids 2011;76(8):777-80.
2011: Siobhan Gallanagh; Elizabeth Mallon; Matthew Walters; Piotr Sonnecki
Fibroelastoma of the mitral valve as a cause of embolic cerebral infarction.
BMJ case reports 2011;2011():.
2010: B Elsberger; R Fullerton; S Zino; F Jordan; T J Mitchell; V G Brunton; Elizabeth Mallon; P G Shiels; J Edwards
Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.
British journal of cancer 2010;103(6):899-909.
2009: Laszlo Romics; Elizabeth Mallon; Robin Reid; CM Cordiner; Julie C Doughty
Osteoclast-like giant cell tumor arising in the soft tissue of the breast: report of a case.
Surgery today 2009;39(1):48-51.
2008: Mitch Dowsett; Craig Allred; Jill Knox; Emma Quinn; Janine Salter; Chris Wale; Jack Cuzick; Joan Houghton; Norman Williams; Elizabeth Mallon; Hugh Bishop; Ian O Ellis; Denis Larsimont; Hironobu Sasano; Pauline Carder; Antonio Llombart Cussac; Fiona Knox; Valerie Speirs; John Forbes; Aman Buzdar
Relationship between quantitative estrogen and progesterone receptor expression and human epidermal growth factor receptor 2 (HER-2) status with recurrence in the Arimidex, Tamoxifen, Alone or in Combination trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1059-65.
2008: Elizabeth Mallon; Zsuzsanna Varga
Relapse of invasive lobular carcinoma.
Breast disease 2008;30():53-6.
2005: Suzanne Hagan; Fahd Al-Mulla; Elizabeth Mallon; Karin Oien; Rhona Ferrier; Barry A Gusterson; Jorge J Curto García; Walter Kolch
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(20):7392-7.
2005: Torsten Stein; Karen N Price; Joanna S Morris; Victoria J Heath; Roderick K Ferrier; Alexandra K Bell; Marie-Anne Pringle; René Villadsen; Ole W Petersen; Guido Sauter; Gareth Bryson; Elizabeth Mallon; Barry A Gusterson
Annexin A8 is up-regulated during mouse mammary gland involution and predicts poor survival in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(19 Pt 1):6872-9.
2005: R Ainsworth; John M S Bartlett; James J Going; Elizabeth Mallon; Amanda Forsyth; J Richmond; W Angerson; Amanda D Watters; Barbara Dunne
IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma.
Journal of clinical pathology 2005;58(10):1086-90.
2003: Mitch Dowsett; John Bartlett; Ian O Ellis; Janine Salter; Margaret Hills; Elizabeth Mallon; Amanda D Watters; Timothy G Cooke; C Paish; P M Wencyk; Sarah Elizabeth Pinder
Correlation between immunohistochemistry (HercepTest) and fluorescence in situ hybridization (FISH) for HER-2 in 426 breast carcinomas from 37 centres.
The Journal of pathology 2003;199(4):418-23.
2003: John Bartlett; Elizabeth Mallon; Timothy G Cooke
The clinical evaluation of HER-2 status: which test to use?
The Journal of pathology 2003;199(4):411-7.
2001: John M S Bartlett; James J Going; Elizabeth Mallon; Amanda D Watters; Jonathan R Reeves; P Stanton; J Richmond; B Donald; Roderick K Ferrier; Timothy G Cooke
Evaluating HER2 amplification and overexpression in breast cancer.
The Journal of pathology 2001;195(4):422-8.
2001: James J Going; Elizabeth Mallon; RE Leake; John M S Bartlett; Barry A Gusterson
What the clinician needs from the pathologist: evidence-based reporting in breast cancer.
European journal of cancer (Oxford, England : 1990) 2001;37 Suppl 7():S5-17.
2000: Ian O Ellis; Mitch Dowsett; J Bartlett; R Walker; T Cooke; W Gullick; B Gusterson; Elizabeth Mallon; P B Lee
Recommendations for HER2 testing in the UK.
Journal of clinical pathology 2000;53(12):890-2.
2000: Elizabeth Mallon; Peter Osin; N Nasiri; I Blain; B Howard; Barry A Gusterson
The basic pathology of human breast cancer.
Journal of mammary gland biology and neoplasia 2000;5(2):139-63.
2000: Mitch Dowsett; Timothy G Cooke; Ian O Ellis; W J Gullick; Barry A Gusterson; Elizabeth Mallon; R Walker
Assessment of HER2 status in breast cancer: why, when and how?
European journal of cancer (Oxford, England : 1990) 2000;36(2):170-6.